XML 24 R13.htm IDEA: XBRL DOCUMENT v3.25.3
Note 8 - Stockholders' Equity
 9 Months Ended
Nov. 01, 2025
Notes to Financial Statements  
Equity [Text Block]

8. Stockholders’ Equity

 

The following table sets forth the changes in stockholders’ equity (in thousands) for the thirteen weeks ended November 1, 2025 and November 2, 2024 (in thousands):

 

  

For the thirteen weeks ended November 1, 2025

  

For the thirteen weeks ended November 2, 2024

 
                                         
  

Common

          

Retained

      

Common

          

Retained

     
  

stock

  

APIC (1)

  

AOCI (2)

  

earnings

  

Total

  

stock

  

APIC (1)

  

AOCI (2)

  

earnings

  

Total

 

Balance, beginning

 $132  $61,701  $(11,304) $104,866  $155,395  $136  $62,831  $(11,913) $74,737  $125,791 

Stock-based compensation

      426           426       346           346 

Share repurchase

  (2)  (788)      (9,405)  (10,195)  (1)  (666)      (4,166)  (4,833)

Cash dividends

              (2,887)  (2,887)              (2,704)  (2,704)

Other comprehensive income (loss)

          (244)      (244)          102       102 

Net income

              8,122   8,122               9,871   9,871 

Balance, ending

 $130  $61,339  $(11,548) $100,696  $150,617  $135  $62,511  $(11,811) $77,738  $128,573 

 

(1) Additional paid-in capital (“APIC”)

(2) Accumulated other comprehensive loss (“AOCI”)

 

The following table sets forth the changes in stockholders’ equity (in thousands) for the thirty-nine weeks ended November 1, 2025 and November 2, 2024 (in thousands):

 

  

For the thirty-nine weeks ended November 1, 2025

  

For the thirty-nine weeks ended November 2, 2024

 
                                         
  

Common

          

Retained

      

Common

          

Retained

     
  

stock

  

APIC (1)

  

AOCI (2)

  

earnings

  

Total

  

stock

  

APIC (1)

  

AOCI (2)

  

earnings

  

Total

 

Balance, beginning

 $133  $61,987  $(12,554) $89,516  $139,082  $142  $66,330  $(12,082) $75,272  $129,662 

Shares issued under employee stock plans

      1,103           1,103   2   1,094           1,096 

Stock-based compensation

      1,085           1,085       1,016           1,016 

Shares withheld in lieu of tax withholdings

      (1,266)          (1,266)  (1)  (2,089)          (2,090)

Share repurchase

  (3)  (1,570)      (15,944)  (17,517)  (8)  (3,840)      (19,333)  (23,181)

Cash dividends

              (8,684)  (8,684)              (8,269)  (8,269)

Other

              -   -               (39)  (39)

Other comprehensive income

          1,006       1,006           271       271 

Net income

              35,808   35,808               30,107   30,107 

Balance, ending

 $130  $61,339  $(11,548) $100,696  $150,617  $135  $62,511  $(11,811) $77,738  $128,573 

 

(1) Additional paid-in capital (“APIC”)

(2) Accumulated other comprehensive loss (“AOCI”)

 

During the thirteen and thirty-nine weeks ended November 1, 2025, the Company utilized $10.1 million in cash to repurchase 168,456 shares and utilized $17.4 million in cash to repurchase 336,041 shares, respectively, under its $100 million dollar stock repurchase program that was authorized by the Board on September 11, 2024 (the "September 2024 Stock Repurchase Program"). Between the end of the third fiscal quarter of 2025 and December 8, 2025, the Company utilized an additional $2.4 million in cash to repurchase 46,831 under the September 2024 Stock Repurchase Program, leaving the aggregate $71.8 million available for future repurchases under that plan.  For the thirteen and thirty-nine weeks ended November 1, 2025, the Board authorized cash dividends to shareholders of $2.9 million and $8.7 million, respectively. Additionally, on November 12, 2025, the Board declared a quarterly cash dividend of $0.22 per share on the issued and outstanding common stock of the company. The dividend will be paid on January 8, 2026, to all stockholders of record as of November 26, 2025.

 

During the thirteen and thirty-nine weeks ended November 2, 2024, the Company utilized $4.8 million in cash to repurchase 147,917 shares and utilized $23.0 million in cash to repurchase 832,944 shares, respectively. During that quarter, the Company repurchased shares under two separate stock repurchase programs. For the thirteen weeks ending November 2, 2024, the company repurchased 73,274 shares utilizing $2.0 million in ash under the Company's $50.0 million program authorized by its Board of Directors on August 31, 2022 (the "August 2022 Stock Repurchase Program"). For the thirteen and thirty-nine weeks ended November 2, 2024, the company utilized $2.8 million in cash to repurchase 74,643 shares under the September 2024 Stock Repurchase Program. For the thirteen and thirty-nine weeks ended November 2, 2024, the Company's Board of Directors authorized cash dividends to shareholders of $2.7 million and $8.3 million, respectively.